These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin. Horadam VW; Smilack JD; Montgomery CL; Werringloer J Antimicrob Agents Chemother; 1980 Oct; 18(4):557-61. PubMed ID: 6934707 [TBL] [Abstract][Full Text] [Related]
3. Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics. Kesado T; Hashizume T; Asahi Y Antimicrob Agents Chemother; 1980 Jun; 17(6):912-7. PubMed ID: 6931548 [TBL] [Abstract][Full Text] [Related]
4. Susceptibilities of anaerobic bacteria to N-formimidoyl thienamycin (MK0787) and to other antibiotics. Kesado T; Watanabe K; Asahi Y; Isono M; Ueno K Antimicrob Agents Chemother; 1982 Jun; 21(6):1016-22. PubMed ID: 6956247 [TBL] [Abstract][Full Text] [Related]
6. Activity of N-formimidoyl thienamycin and cephalosporins against isolates from nosocomially acquired bacteremia. Gutiérrez-Núñez J; Harrington PT; Ramirez-Ronda CH Antimicrob Agents Chemother; 1982 Mar; 21(3):509-12. PubMed ID: 6954876 [TBL] [Abstract][Full Text] [Related]
7. N-formimidoyl thienamycin (MK0787): in vitro activity against anaerobic bacteria. Martin DA; Sanders CV; Marier RL Antimicrob Agents Chemother; 1982 Jan; 21(1):168-9. PubMed ID: 6952818 [TBL] [Abstract][Full Text] [Related]
8. A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives. Cullmann W; Opferkuch W; Stieglitz M; Werkmeister U Antimicrob Agents Chemother; 1982 Aug; 22(2):302-7. PubMed ID: 6821459 [TBL] [Abstract][Full Text] [Related]
9. MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities. Kropp H; Sundelof JG; Kahan JS; Kahan FM; Birnbaum J Antimicrob Agents Chemother; 1980 Jun; 17(6):993-1000. PubMed ID: 6931549 [TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of N-formimidoyl thienamycin (MK0787) combined with amikacin against gram-negative bacilli and Staphylococcus aureus. Díez Enciso M; Mateos Lindemann M; Gutiérrez Altés A Antimicrob Agents Chemother; 1982 Dec; 22(6):1064-6. PubMed ID: 6818899 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of N-formimidoyl thienamycin (MK0787) against resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens, and Enterococcus spp. Livingston WK; Elliott AM; Cobbs CG Antimicrob Agents Chemother; 1981 Jan; 19(1):114-6. PubMed ID: 6787975 [TBL] [Abstract][Full Text] [Related]
12. In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime. Verbist L; Verhaegen J Antimicrob Agents Chemother; 1981 Mar; 19(3):402-6. PubMed ID: 6264844 [TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability. Neu HC; Labthavikul P Antimicrob Agents Chemother; 1982 Jan; 21(1):180-7. PubMed ID: 6979306 [TBL] [Abstract][Full Text] [Related]
15. In-vitro activity of MK0787 (N-formimidoyl thienamycin) against Pseudomonas aeruginosa and other Gram-negative organisms and its stability to their beta-lactamases. Livermore DM; Williams RJ; Williams JD J Antimicrob Chemother; 1981 Nov; 8(5):355-62. PubMed ID: 6798011 [No Abstract] [Full Text] [Related]
16. Comparative in vitro activities of N-formimidoyl thienamycin and moxalactam against nonfermentative aerobic gram-negative rods. O'Donnell ED; Freimer EH; Gilardi GL; Raeder R Antimicrob Agents Chemother; 1982 Apr; 21(4):673-5. PubMed ID: 6211143 [TBL] [Abstract][Full Text] [Related]
17. Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa. Corrado ML; Landesman SH; Cherubin CE Antimicrob Agents Chemother; 1980 Dec; 18(6):893-6. PubMed ID: 6263178 [TBL] [Abstract][Full Text] [Related]
18. Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin. Braveny I; Machka K; Elsser R Infection; 1982 Jan; 10(1):45-9. PubMed ID: 6279523 [TBL] [Abstract][Full Text] [Related]
19. In vitro comparison of N-formimidoyl thienamycin (MK0787) and Azlocillin with three aminoglycosides and ticarcillin against Pseudomonas aeruginosa. Matzkowitz AJ; Baltch AL; Smith RP; Sutphen NT; Hammer MC; Conroy JV Antimicrob Agents Chemother; 1982 Apr; 21(4):685-7. PubMed ID: 6805426 [TBL] [Abstract][Full Text] [Related]
20. Effect of N-formimidoyl thienamycin (MK0787) on beta-lactamases and activity against beta-lactamase-producing strains. Toda M; Sato K; Nakazawa H; Inoue M; Mitsuhashi S Antimicrob Agents Chemother; 1980 Nov; 18(5):837-8. PubMed ID: 6969580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]